Revascularization Strategies for Stable Left Main Coronary Artery Disease: Analysis of Current Evidence

Shashank Shekhar; Divyanshu Mohananey; Pedro Villablanca; Sudhi Tyagi; Juan A Crestanello; Iván J Núñez Gil; Harish Ramakrishna

doi:10.1053/j.jvca.2021.12.016

Revascularization Strategies for Stable Left Main Coronary Artery Disease: Analysis of Current Evidence

J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3370-3378. doi: 10.1053/j.jvca.2021.12.016. Epub 2021 Dec 20.

Authors

Shashank Shekhar¹, Divyanshu Mohananey², Pedro Villablanca³, Sudhi Tyagi², Juan A Crestanello⁴, Iván J Núñez Gil⁵, Harish Ramakrishna⁶

Affiliations

¹ Department of Cardiovascular Medicine, Heart, and Vascular Institute, Cleveland Clinic, Cleveland, OH.
² Department of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI.
³ Interventional Cardiology, Henry Ford Hospital, Detroit, MI.
⁴ Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN.
⁵ Interventional Cardiology Consultant, Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.
⁶ Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: [email protected].

PMID: 35115224
DOI: 10.1053/j.jvca.2021.12.016

No abstract available

Keywords: LMCAD; clinical trials; coronary artery bypass grafting; ischemic heart disease; left main coronary artery disease; percutaneous coronary intervention.

Publication types

Review

MeSH terms

Coronary Artery Bypass
Coronary Artery Disease* / surgery
Humans
Percutaneous Coronary Intervention*
Treatment Outcome